Outset Medical raised $76.5 million in its Series C round, which will go toward scaling up the commercial launch of its all-in-one dialysis device.
Singapore’s state-owned investment firm Temasek and Chinese internet tycoon Jack Ma-backed Yunfeng Capital have led a $75 million Series B into WuXi NextCODE.
The Abu Dhabi Investment Authority and Singapore’s GIC have bought a minority stake in PPD, valuing the CRO giant at more than $9 billion.
Ion channel CRO Metrion Biosciences has reached a collaboration agreement with Venomtech to utilize the latter’s venom library in search of novel ion channel…
NCGS is expanding its business by relocating to a new corporate headquarters, bringing $10 million in investment and creating 80 new jobs.
Amid new approvals last year, drugmakers also suffered R&D setbacks, cut research staff, rejigged their operations and refocused their pipelines.
French pharma Onxeo is teaming up with CRO Clinigen to bring blood cancer med belinostat to European patients in dire need through a managed access program.
After raising $31 million just last year, California-based clinical research company Science 37 has now served up a Series C round worth $29 million.
An expert panel has released new guidelines for modern clinical trials, examining the importance of utilizing telehealth technologies in clinical studies.
Medidata is acquiring Mytrus, together with its industry-first electronic informed consent service.